Urgent care study of the LumiraDx SARS-CoV-2 Ag Test for rapid diagnosis of COVID-19

Table 2 SARS-CoV-2 test results from LumiraDx SARS-CoV-2 Ag Test and PCR-based test

SARS CoV-2 rapid antigen tests
Total antigen tests conducted^a Positive antigen results rendered Negative antigen results rendered	2241 549 (24.5%) 1692 (75.5%)
PCR-based SARS CoV-2 tests
Total PCR-based tests conducted^b Positive PCR results rendered Negative PCR results rendered	800 30 (3.8%) 770 (96.3%)

^aAll SARS-CoV-2 antigen testing (n = 2241) were conducted using the rapid, point-of-care LumiraDx SARS-CoV-2 Ag Test on patients presenting to an urgent care center
^bDuring the initial clinical and risk assessment, a subset of patients (n = 800) that tested negative with the LumiraDx SARS-CoV-2 Ag Test was also tested with a PCR-based method for SARS-CoV-2

ISSN: 2397-7523